Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Imaflex acquires pesticide film technology from Bayer

The Canadian company, Imaflex (Montreal, Quebec), has acquired the global rights and assets to Advaseal, a plastic film formulation for the controlled release of pesticides, from Bayer subsidiary Bayer Innovation. The acquisition includes the herbicide-coated product, Advaseal HSM, which has received US EPA approval for the control of broadleaf weeds and sedges, and also reduces fumigant emissions. Imaflex plans to introduce the product in spring 2015. The Advaseal technology differs from Imaflex's proprietary co-extruded agricultural film technology in being able to release herbicides, fungicides and nematicides simultaneously, which is a pre-requisite for fumigant replacement products, the company notes. It can be processed at ambient temperatures, allowing use with biological products. Imaflex plans to submit its first co-extruded herbicide film formulation for US registration next year.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG002957

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel